A Los Angeles jury ruled Johnson & Johnson was not liable for ovarian cancer claims linked to its talc-based baby powder.
A Los Angeles jury determined Johnson & Johnson was not negligent in a lawsuit alleging its talc products caused ovarian cancer in three women. The case involved families of three deceased plaintiffs who claimed prolonged use of the company’s talc-based baby powder led to their deaths. Over 67,000 similar lawsuits have been filed against the firm, which discontinued talc-based powder sales in the U.S. in 2020, shifting to a cornstarch alternative.
The ruling contrasts with prior legal challenges targeting JNJ’s talc products, which have resulted in billions in settlements and verdicts. The company continues to face ongoing litigation despite the recent verdict. Separately, JNJ launched its Dual Energy THERMOCOOL SMARTTOUCH SF Platform in Europe, citing 86.9% effectiveness in 12-month data.
The healthcare giant operates through Innovative Medicine and MedTech segments, focusing on AI-driven advancements in medical technology.